Form 8-K - Current report:
SEC Accession No. 0001789769-25-000074
Filing Date
2025-07-31
Accepted
2025-07-31 16:31:09
Documents
12
Period of Report
2025-07-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K til-20250731.htm   iXBRL 8-K 30765
  Complete submission text file 0001789769-25-000074.txt   149544

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20250731.xsd EX-101.SCH 1773
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20250731_lab.xml EX-101.LAB 22530
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20250731_pre.xml EX-101.PRE 13038
14 EXTRACTED XBRL INSTANCE DOCUMENT til-20250731_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 251172140
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)